Literature DB >> 29844762

Seizures in Tuberous Sclerosis: Mechanism-Based Interventions EXIST.

Mohamad Koubeissi.   

Abstract

Entities:  

Year:  2018        PMID： 29844762      PMCID： PMC5967581          DOI： 10.5698/1535-7597.18.1.39

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  7 in total

1.  Epidemiology of tuberous sclerosis.

Authors:  J P Osborne; A Fryer; D Webb
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Authors:  Orrin Devinsky; J Helen Cross; Linda Laux; Eric Marsh; Ian Miller; Rima Nabbout; Ingrid E Scheffer; Elizabeth A Thiele; Stephen Wright
Journal:  N Engl J Med       Date:  2017-05-25       Impact factor: 91.245

3.  Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Lin Xu; David H Gutmann; Michael Wong
Journal:  Ann Neurol       Date:  2008-04       Impact factor: 10.422

4.  Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder.

Authors:  Whitney E Parker; Ksenia A Orlova; William H Parker; Jacqueline F Birnbaum; Vera P Krymskaya; Dmitry A Goncharov; Marianna Baybis; Jelte Helfferich; Kei Okochi; Kevin A Strauss; Peter B Crino
Journal:  Sci Transl Med       Date:  2013-04-24       Impact factor: 17.956

5.  The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.

Authors:  Ling-Hui Zeng; Nicholas R Rensing; Michael Wong
Journal:  J Neurosci       Date:  2009-05-27       Impact factor: 6.167

6.  Long-term treatment of epilepsy with everolimus in tuberous sclerosis.

Authors:  Darcy A Krueger; Angus A Wilfong; Maxwell Mays; Christina M Talley; Karen Agricola; Cindy Tudor; Jamie Capal; Katherine Holland-Bouley; David Neal Franz
Journal:  Neurology       Date:  2016-11-04       Impact factor: 9.910

7.  Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.

Authors:  Darcy A Krueger; Hope Northrup
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.